Glioblastoma Foundation Inc
Why pick this one
Glioblastoma Foundation funds targeted small-molecule drug development and operates a genomic testing and research laboratory in Durham, North Carolina.
Best for
- Donors seeking to fund targeted glioblastoma drug development
- Glioblastoma research involving patient-derived xenograft models
- Personalized treatment research based on tumor genomic profiles
- Volunteers seeking glioblastoma-related opportunities
- Patients and families seeking glioblastoma treatment information
Look elsewhere if
- Seeking emergency medical care
- Seeking routine hospital-based glioblastoma treatment
- Seeking general cancer services outside glioblastoma research and treatment information
Specialties
- Targeted small-molecule drug development for glioblastoma
- Patient-derived glioblastoma xenograft research
- Glioblastoma genomic testing
- Personalized glioblastoma therapy research
What makes them different
- Opened a Glioblastoma Foundation Genomic Testing & Research Laboratory in Durham, North Carolina, in 2024
- Supports development of a panel of more than 50 patient-derived glioblastoma xenografts
- Focuses on therapies based on the molecular features of individual tumors
- Advisory board includes Duke University Medical Center and Duke Law Center for Innovation Policy experts
- Acquired Lisavanbulin from Basilea Pharmaceutica for a post-trial access program involving three patients in the UK
Distilled from this business's own website.
Contact & Location
- Address
- 2451 Croasdaile Farm Pkwy Ste 109, Durham, NC 27705
- Phone
- 9194021775
- Website
- https://glioblastomafoundation.org/
Services
- Funding glioblastoma drug research
- Genomic testing and research
- Patient information about glioblastoma treatment options
- Volunteer opportunities
- Fundraising and donation programs